THE GREATER GOOD PART III: Current vaccination practices for chickenpox, shingles, rotavirus, and MMR do not protect the immuno-compromised.

The greater good and the protection of the immunocompromised is often cited as the primary rationale for mandatory vaccination. It is currently be used as motivation to remove NJ’s Religious Exemption. This idea is untenable. We’ve addresses that a number of vaccines do not claim to protect the greater good (Part I). We’ve also address how vaccines have yet to provide herd immunity due to primary (low responders) and secondary (early waners) vaccine failure (Part II).

Here in Part III we examine how current vaccination practices do not protect the immuno-compromised for the live chickenpox, shingles, rotavirus, and MMR vaccines. Any time the safety precautions listed on the vaccines label are not followed, the greater good and immunocompromised are put at risk due to live vaccines shedding.   

  • Chicken Pox: (https://www.merck.com/product/usa/pi_circulars/v/varivax/varivax_pi.pdf)  The vaccine label states: “Due to the concern for transmission of vaccine virus, vaccine recipients should attempt to avoid whenever possible close association with susceptible high-risk individuals for up to six weeks following vaccination with VARIVAX. Susceptible high-risk individuals include:
    • Immunocompromised individuals;
    • Pregnant women without documented history of varicella or laboratory evidence of prior infection;
    • Newborn infants of mothers without documented history of varicella or laboratory evidence of prior infection and all newborn infants born at <28 weeks gestation regardless of maternal varicella immunity.
  • Furthermore, the vaccine label states “post-marketing experience suggests that transmission of vaccine virus may occur rarely between healthy vaccinees who develop a varicella-like rash and healthy susceptible contacts.”
  • Furthermore the insert states “One clinical trial demonstrated that vaccinees transmit vaccine virus to healthy seronegative contacts [see Clinical Pharmacology].”